United States · FDA National Drug Code directory
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71921-188_41d7b9be-f2ee-4cb5-ae7e-dcb281591b53
- Product NDC
- 71921-188
- Form
- SOLUTION
- Composition / generic term
- Brimonidine tartrate and Timolol maleate
- Labeler
- Florida Pharmaceutical Products, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231123
- Source listing expiry
- 20271231
Source-listed ingredients
- BRIMONIDINE TARTRATE — 2 mg/mL
- TIMOLOL MALEATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (71921-188-05) / 5 mL in 1 BOTTLE, DROPPER · 71921-188-05
- 1 BOTTLE, DROPPER in 1 CARTON (71921-188-10) / 10 mL in 1 BOTTLE, DROPPER · 71921-188-10
- 1 BOTTLE, DROPPER in 1 CARTON (71921-188-15) / 15 mL in 1 BOTTLE, DROPPER · 71921-188-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →